Price T Rowe Associates Inc Aim Immuno Tech Inc. Transaction History

Price T Rowe Associates Inc

  • $836 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.32 - $0.77 $30,528 - $73,458
-95,400 Reduced 82.45%
20,300 $9,000
Q3 2022

Nov 14, 2022
SELL
$0.57 - $0.81 $627 - $891
-1,100 Reduced 0.94%
115,700 $68,000
Q4 2020

Feb 16, 2021
BUY
$1.68 - $2.45 $196,224 - $286,160
116,800 New
116,800 $209,000

Others Institutions Holding AIM

# of Institutions
39
Shares Held
8.44M
Call Options Held
0
Put Options Held
0
View Full List

About AIM ImmunoTech Inc.

AIM Quotes by TradingView
  • Ticker AIM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,049,300
  • Market Cap $12M
  • Description
  • AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...
More about AIM
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email